BioSpace News Archive

20n Bio Appoints Linghang Zhuang, Ph.D., as President, to lead the discovery of cyclic peptide drugs

-20n Bio, a biotechnology company specializing in peptide drug discovery, announced the appointment of Linghang Zhuang, PhD, as President, effective February 1

January 29, 2024
·
2 min read
Skye Bioscience Announces $50.25 Million Private Placement Equity Financing

Skye Bioscience, Inc. (OTCQB: SKYE) (“the Company”), a clinical stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system

January 29, 2024
·
7 min read
Drug Development

EILEAN THERAPEUTICS INITIATES FIRST IN HUMAN TRIAL WITH EILETOCLAX, A SELECTIVE BCL2 INHIBITOR WITH LIMITED IMMUNE SUPPRESSION AND IMPROVED SAFETY COMPARED TO VENETOCLAX AND VENETOCLAX-LIKE MOLECULES

Eilean Therapeutics LLC today announced the clearance from the Human Research Ethics Committee in Australia to begin human dosing in the Phase 1 clinical program of eiletoclax, a highly potent and selective BCL2 inhibitor.

January 29, 2024
·
2 min read
Pharma-Bio Serv Announces Full Year Results - Jan 29, 2024

Pharma-Bio Serv, Inc. announced that revenues for the year ended October 31, 2023 were approximately $17.0 million, a decrease of approximately $2.4 million when compared to last year.

January 29, 2024
·
2 min read
Biotech Beach

Copan Colibrí™ Receives Third FDA Clearance, Further Expanding Automated ID/AST Workup Capabilities

Copan Diagnostics, a leader in Clinical Microbiology automation solutions, has announced the third FDA clearance for its innovative pre-analytical processor, Colibrí™.

January 29, 2024
·
4 min read
Beckman Coulter Unveils DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance

Beckman Coulter Diagnostics, a clinical diagnostics leader, will unveil its new DxC 500 AU Chemistry Analyzer, an automated clinical chemistry analyzer, at Medlab Middle East in Dubai, taking place February 5-8, 2024.

January 29, 2024
·
3 min read
Business

Inotiv, Inc. to Report Fiscal 2024 First Quarter Financial Results and Host Conference Call on Wednesday, February 7, 2024

Inotiv, Inc. announced that it will issue its financial results for the fiscal 2024 first quarter ended December 31, 2023, on Wednesday, February 7, 2024, after the close of the stock market.

January 29, 2024
·
2 min read
Pharm Country

Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) today announced that Chief Executive Officer Jon Congleton will be participating in a fireside chat at the Guggenheim Securities 6th Annual Biotechnology Conference, being held in New York City on February 7-8, 2024.

January 29, 2024
·
1 min read
Business

Dentsply Sirona to Host Fourth Quarter and Full Year 2023 Conference Call on February 29th

DENTSPLY SIRONA Inc. announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 29, 2024, at 8:30 am ET to review its fourth quarter and full year 2023 financial results.

January 29, 2024
·
1 min read
BioCapital

Castellum Announces Closing of $2.7 Million Registered Direct Offering

Castellum, Inc. announced the closing of its previously announced registered direct offering, consisting of the sale of 8,437,501 shares of common stock.

January 29, 2024
·
4 min read